Evidence map›Paper›PMID 41961312›Full record

ArticleMolecular biology reports2026

Illuminating the pleiotropic effects of bixin-loaded nanoemulsion on glioblastoma cell behavior through an integrated approach.

Ressin Varghese, Brigitte Vannier, Marc Mesnil, Mohanraj Gopikrishnan, George Priya Doss C, Natarajan Chandrasekaran, Siva Ramamoorthy

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ressin VargheseSchool of Bio Sciences and Technology, Vellore Institute of Technology, Vellore, 632014, Tamil Nadu, India.
Brigitte VannierCoMeT Laboratory, Microenvironment of Tumours, Université of Poitiers, 1Rue Georges Bonnet, TSA 51 106, Poitiers Cedex 9, Poitiers, 24344, 86073, UR, France.
Marc MesnilCoMeT Laboratory, Microenvironment of Tumours, Université of Poitiers, 1Rue Georges Bonnet, TSA 51 106, Poitiers Cedex 9, Poitiers, 24344, 86073, UR, France.
Mohanraj GopikrishnanSchool of Bio Sciences and Technology, Vellore Institute of Technology, Vellore, 632014, Tamil Nadu, India.
George Priya Doss CSchool of Bio Sciences and Technology, Vellore Institute of Technology, Vellore, 632014, Tamil Nadu, India.
Natarajan ChandrasekaranCenter for Nanobiotechnology, Vellore Institute of Technology, Vellore, 632014, Tamil Nadu, India.
Siva RamamoorthySchool of Bio Sciences and Technology, Vellore Institute of Technology, Vellore, 632014, Tamil Nadu, India. siva.ramamoorthy@gmail.com.ORCID http://orcid.org/0000-0001-7509-8602

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGlioblastoma is a pervasive brain cancer characterized by extreme aggressiveness and death rates. The high fatality rate of GBM is accentuating the need for efficient natural alternatives, such as bixin. Bixin is an apocarotenoid abundant in Bixa orellana L. Despite its prominent coloring potential, the structural distinctiveness and remarkable antioxidant potential confer bixin therapeutic efficacy in ameliorating cancers in experimental models. Therefore, the present study developed a bixin-loaded nanoemulsion (BNE) to investigate the pleiotropic effects of bixin on GBM. METHODS AND

resultsAn integrated approach comprising in-vitro and in-silico analyses was adopted to elucidate the pharmaceutical potential of bixin in targeting key signaling molecules involved in proliferation, migration, and invasion. Interestingly, BNE suppressed the proliferation of GB cells in a concentration-dependent manner. Furthermore, BNE curbed the invasion and migration of Ln-229 cells, as evidenced in migration and invasion assays. BNE downregulated the expression of cortactin, a key protein involved in the invadopodia formation for the motility of GBM cells. The western blot analysis substantiated that BNE acts on PTEN/PI3K/AKT signaling and the ERK1/2 pathway to impede the proliferation of Ln-229 cells. Moreover, BNE curtailed the migration and invasion of Ln-229 cells by targeting FAK/Src signaling and by downregulating MMP9 expression. In silico analysis, including docking studies and molecular dynamics simulations, further corroborated the interaction of selected target proteins with bixin.

conclusionTaking together, our findings revealed that bixin has therapeutic potential in mitigating GBM cell behavior by acting on multiple targets to limit its proliferation, migration, and invasion.

Indexed as

Brain NeoplasmsCarotenoidsGlioblastomaApoptosis Regulatory ProteinsCell Line, TumorCell MovementCell ProliferationEmulsionsHumansMolecular Docking SimulationNeoplasm InvasivenessSignal TransductionApoptosis Regulatory ProteinsbixinCarotenoidsEmulsionsBixinGlioblastomaInvasionNanoemulsionProliferation

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.